Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phyllis J Goodman

Showing results (61-70 of 157) with videos related to

Pageof 16
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|October 26, 2016
Colorectal Adenomas in Participants of the SELECT Randomized Trial of Selenium and Vitamin E for Prostate Cancer PreventionPeter Lance, David S Alberts, Patricia A Thompson, et al.
Journal of the National Cancer Institute|July 12, 2013
Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trialTheodore M Brasky, Amy K Darke, Xiaoling Song, et al.
The Prostate|June 8, 2020
The association between serum sex steroid hormone concentrations and intraprostatic inflammation in men without prostate cancer and irrespective of clinical indication for biopsy in the placebo arm of the Prostate Cancer Prevention TrialSusan Chadid, John R Barber, William G Nelson, et al.
Cancer Epidemiology|June 25, 2018
The scientific impact and value of large, NCI-sponsored randomized phase III cancer chemoprevention trialsJoseph M Unger, William E Barlow, Catherine M Tangen, et al.
The American Journal of Clinical Nutrition|January 18, 2022
Change in plasma α-tocopherol associations with attenuated pulmonary function decline and with CYP4F2 missense variationJiayi Xu, Kristin A Guertin, Nathan C Gaddis, et al.
Cancer Causes & Control : CCC|July 20, 2012
Prospective study of cytomegalovirus serostatus and prostate cancer risk in the Prostate Cancer Prevention TrialSiobhan Sutcliffe, Cathee Till, Charlotte A Gaydos, et al.
The New England Journal of Medicine|May 28, 2004
Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliterIan M Thompson, Donna K Pauler, Phyllis J Goodman, et al.
Journal of the National Cancer Institute|February 25, 2014
Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer riskAlan R Kristal, Amy K Darke, J Steven Morris, et al.
Respiratory Research|April 19, 2015
A randomized controlled trial of vitamin E and selenium on rate of decline in lung functionPatricia A Cassano, Kristin A Guertin, Alan R Kristal, et al.
Clinical Trials (London, England)|October 16, 2012
Moving a randomized clinical trial into an observational cohortPhyllis J Goodman, Jo Ann Hartline, Catherine M Tangen, et al.
Pageof 16

Showing results (61-70 of 157) with videos related to

Sort By:
Pageof 16
Cancer Prevention Research (Philadelphia, Pa.)|October 26, 2016
Colorectal Adenomas in Participants of the SELECT Randomized Trial of Selenium and Vitamin E for Prostate Cancer PreventionPeter Lance, David S Alberts, Patricia A Thompson, et al.
Journal of the National Cancer Institute|July 12, 2013
Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trialTheodore M Brasky, Amy K Darke, Xiaoling Song, et al.
The Prostate|June 8, 2020
The association between serum sex steroid hormone concentrations and intraprostatic inflammation in men without prostate cancer and irrespective of clinical indication for biopsy in the placebo arm of the Prostate Cancer Prevention TrialSusan Chadid, John R Barber, William G Nelson, et al.
Cancer Epidemiology|June 25, 2018
The scientific impact and value of large, NCI-sponsored randomized phase III cancer chemoprevention trialsJoseph M Unger, William E Barlow, Catherine M Tangen, et al.
The American Journal of Clinical Nutrition|January 18, 2022
Change in plasma α-tocopherol associations with attenuated pulmonary function decline and with CYP4F2 missense variationJiayi Xu, Kristin A Guertin, Nathan C Gaddis, et al.
Cancer Causes & Control : CCC|July 20, 2012
Prospective study of cytomegalovirus serostatus and prostate cancer risk in the Prostate Cancer Prevention TrialSiobhan Sutcliffe, Cathee Till, Charlotte A Gaydos, et al.
The New England Journal of Medicine|May 28, 2004
Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliterIan M Thompson, Donna K Pauler, Phyllis J Goodman, et al.
Journal of the National Cancer Institute|February 25, 2014
Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer riskAlan R Kristal, Amy K Darke, J Steven Morris, et al.
Respiratory Research|April 19, 2015
A randomized controlled trial of vitamin E and selenium on rate of decline in lung functionPatricia A Cassano, Kristin A Guertin, Alan R Kristal, et al.
Clinical Trials (London, England)|October 16, 2012
Moving a randomized clinical trial into an observational cohortPhyllis J Goodman, Jo Ann Hartline, Catherine M Tangen, et al.
Pageof 16